ArticleBone marrow transplantation2004

HER2 overexpression as a prognostic factor in metastatic breast cancer patients treated with high-dose chemotherapy and autologous stem cell support.

V Guarneri et al.PubMed ↗Publisher ↗

No numbers read from the abstract.